Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2012
03/29/2012WO2011133695A3 Materials and methods for nucleic acid fractionation by solid phase entrapment and enzyme-mediated detachment
03/29/2012WO2011130666A9 Plants with altered cell wall biosynthesis and methods of use
03/29/2012WO2011116107A3 Cleavable modifications to reducible poly (amido ethylenimines)s to enhance nucleotide delivery
03/29/2012WO2011115366A3 Identification method of species of diatoms in coast of korea, and polynucleotide probe, dna chip and kit for identification of species of diatoms according to same
03/29/2012WO2011112935A3 Antibody fusion proteins with disrupted heparin-binding activity
03/29/2012WO2011112380A3 Two novel alkylresorcinol synthase genes from sorghum; cloning, expression, transformation and characterization
03/29/2012WO2010142981A3 Composition and uses thereof
03/29/2012US20120079628 Compositions and methods for modulation of plant cell division
03/29/2012US20120079627 Plant gene regulatory elements
03/29/2012US20120079623 Yield Enhancement in Plants by Modulation of a ZM-ZFP1 Protein
03/29/2012US20120079622 Yield Enhancement in Plants by Modulation of a ZM-LOBDP1 Protein
03/29/2012US20120079620 Storage-induced promoter
03/29/2012US20120079617 Pepper hybrid ps16364674
03/29/2012US20120079616 Npc1l1 (npc3) and methods of use thereof
03/29/2012US20120079613 Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity
03/29/2012US20120079611 Tl1a model of inflammation fibrosis and autoimmunity
03/29/2012US20120077966 Polynucleotide and polypeptide sequence and methods thereof
03/29/2012US20120077964 Antagonists of pcsk9
03/29/2012US20120077870 Materials and Methods for the Treatment of Pathological Neovascularization in the Eye
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077864 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
03/29/2012US20120077862 Antisense modulation of ptp1b expression
03/29/2012US20120077861 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
03/29/2012US20120077860 Adeno-Associated Viral Vector for Exon Skipping in a Gene Encoding a Dispensable Domain Protein
03/29/2012US20120077751 Methods for modulating neuronal responses
03/29/2012US20120077750 Use of a growth-stimulating protein
03/29/2012US20120077740 Methods for making Apo-2 Ligand using divalent metal ions
03/29/2012US20120077731 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
03/29/2012US20120077713 Collection and Methods for its Use
03/29/2012US20120077710 Method for an in vitro molecular evolution of antibody function
03/29/2012US20120077706 Method for assaying protein-protein interaction
03/29/2012US20120077273 Methods and Compositions for Limiting Viability of a Modified Host Cell Outside of Designated Process Conditions
03/29/2012US20120077270 Control of Gene Expression Using a Complex of an Oligonucleotide and a Regulatory Peptide
03/29/2012US20120077266 Highly thermostable fluorescent proteins
03/29/2012US20120077265 MicroRNA and Methods for Inhibiting Same
03/29/2012US20120077264 Methods for plant transformation using spectinomycin selection
03/29/2012US20120077239 Thermophilic Organisms For Conversion Of Lignocellulosic Biomass To Ethanol
03/29/2012US20120077236 3-hydroxypropionic acid and other organic compounds
03/29/2012US20120077228 OVEREXPRESSION OF AMINOACYL-tRNA SYNTHETASES FOR EFFICIENT PRODUCTION OF ENGINEERED PROTEINS CONTAINING AMINO ACID ANALOGUES
03/29/2012US20120077227 Expression Process
03/29/2012US20120077226 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
03/29/2012US20120077225 Melibiose operon expression system
03/29/2012US20120077224 unnatural amino acid incorporation in eukaryotic cells
03/29/2012US20120077204 Detection of Protein Translocation by Beta-Galactosidase Reporter Fragment Complementation
03/29/2012US20120077203 Reporter gene construct, assay kit and detection method
03/29/2012US20120076853 Composition for use in gene therapy
03/29/2012US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
03/29/2012US20120076828 Kanamycin antisense nucleic acid for the treatment of cancer
03/29/2012US20120076826 Recombinantly Produced Allergens
03/29/2012US20120076823 Vector
03/29/2012US20120076820 Cd40l vaccines, compositions, and methods related thereto
03/29/2012US20120076816 Novel malaria vaccine
03/29/2012US20120076815 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/29/2012US20120076812 Antiviral vaccines with improved cellular immunogenicity
03/29/2012US20120076811 Immunodominant compositions and methods of use therefor
03/29/2012US20120076807 Plasmids with immunological action
03/29/2012US20120076803 Antibodies to troponin i and methods of use thereof
03/29/2012US20120076799 Antagonists of pcsk9
03/29/2012US20120076798 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076764 Methods and pharmaceutical compositions for healing wounds
03/29/2012US20120076763 Combination anti-hiv vectors, targeting vectors, and methods of use
03/29/2012US20120076762 Induced pluripotent stem cell generation using two factors and p53 inactivation
03/29/2012US20120076761 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease
03/29/2012US20120076758 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012US20120074247 Wheat with altered branching enzyme activity and starch containing products derived therefrom
03/29/2012DE102005001889B4 Verfahren zur Steigerung der Bindungskapazität und -effizienz eines Proteins, das nicht methylierte CPG-Motive enthaltende DNA spezifisch bindet A method for enhancing the capacity and efficiency of a binding protein which specifically binds non-methylated CpG motifs containing DNA
03/29/2012CA2849390A1 Metabolic control of seed germination
03/29/2012CA2812724A1 Plants resistant to fungal pathogens and methods for production thereof
03/29/2012CA2812506A1 Plants having enhanced yield-related traits and method for making the same
03/29/2012CA2812380A1 Transgenic plants
03/29/2012CA2812287A1 Direct blood assay for detection of circulating microrna in cancer patients
03/29/2012CA2812096A1 Oncolytic adenoviral vectors and methods and uses related thereto
03/29/2012CA2812093A1 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
03/29/2012CA2812058A1 Dissociation of product-complexed contaminants in chromatography
03/29/2012CA2811878A1 Method for producing cruciferous plant resistant to clubroot
03/29/2012CA2811739A1 Recombinant viral vectors and methods for inducing an immune response to yellow fever virus
03/29/2012CA2811734A1 Multimeric il-15 soluble fusion molecules and methods of making and using same
03/29/2012CA2811297A1 Method of recombinant macromolecular production
03/29/2012CA2811185A1 Increasing confidence of allele calls with molecular counting
03/29/2012CA2810931A1 Direct capture, amplification and sequencing of target dna using immobilized primers
03/29/2012CA2809858A1 Novel low molecular weight cationic lipids for oligonucleotide delivery
03/28/2012EP2434022A2 Use of A33 antigens and JAM-IT
03/28/2012EP2434020A2 Method of producing minus strand RNA virus vector with the use of hybrid promoter containing cytomegalovirus enhancer and avian beta-actin promoter
03/28/2012EP2434019A1 Process for the production of fine chemicals
03/28/2012EP2434018A2 A novel beta-galactoside-alpha2, 3-sialyltransferase, a gene encoding thereof, and a method for producing thereof
03/28/2012EP2434017A2 Identification of a micro-RNA that activates expression of beta-myosin heavy chain
03/28/2012EP2434016A2 Expression of mammalian proteins in Pseudomonas fluorescens
03/28/2012EP2434015A1 DNA fragment having promoter function
03/28/2012EP2434014A1 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same
03/28/2012EP2434013A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof
03/28/2012EP2434012A1 Vector material for creating pluripotent stem cells, and pluripotent stem cell creation method using said vector material
03/28/2012EP2434011A1 Glucosyltransferase specific to position-4 of furofuran-type lignan, and polynucleotide encoding same
03/28/2012EP2434010A1 Prophylactic and/or therapeutic agent for metabolic syndrome
03/28/2012EP2434009A1 Modulation of WRN-mediated telomere-initiated cell signaling
03/28/2012EP2434008A1 Laccases for pulp bio-bleaching
03/28/2012EP2433645A1 Novel malaria vaccine
03/28/2012EP2433642A2 Modified proteases that inhibit complement activation
03/28/2012EP2433641A1 Obligate heterodimer meganucleases and uses thereof
1 ... 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 ... 4023